(Total Views: 86)
Posted On: 10/10/2019 11:00:17 AM
Post# of 9163

$ISWH “Now that Q3 is in the books, we wanted to update shareholders and inform the world that we did achieve our expectations for Q3 performance as stated in our mid-quarter update: we will be reporting our first ever quarter of profitability on an EBITDA basis, and growth in revenues continues to accelerate,” commented Terry Williams, ISWH CEO. “We anticipate that Q4 will be our second quarter in a row to show profits as well, and we should also post accelerating growth in both major segments, Spirits and Health & Wellness, into year-end.”
Management notes that the remainder of the 2019 fiscal year should be marked by accelerating growth in spirits sales, sales of the Company’s P19 CBD products, and client and sales growth for the Company’s Home Healthcare business. The Company also anticipates the start of P19 CBD product sales in physical stores during this quarter, with details on a new strategic partnership set to be announced over the near-term. Sees Record Q3: 79% Sequential Rev Growth, EBITDA Profitable, Accelerating Growth in Q4
https://www.globenewswire.com/news-release/20...in-Q4.html
Management notes that the remainder of the 2019 fiscal year should be marked by accelerating growth in spirits sales, sales of the Company’s P19 CBD products, and client and sales growth for the Company’s Home Healthcare business. The Company also anticipates the start of P19 CBD product sales in physical stores during this quarter, with details on a new strategic partnership set to be announced over the near-term. Sees Record Q3: 79% Sequential Rev Growth, EBITDA Profitable, Accelerating Growth in Q4
https://www.globenewswire.com/news-release/20...in-Q4.html

